Patient perceptions of diabetes and diabetes therapy: Assessing quality of life

Diabetes/Metabolism Research and Reviews

Volumn 18, Issue SUPPL. 3, 2002, Pages

  Bradley, Clare ^a   Speight, Jane ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Audit of diabetes dependent quality of life; Diabetes Treatment Satisfaction Questionnaire; Insulin glargine; Insulin lispro

Indexed keywords

GLIMEPIRIDE; INSULIN; INSULIN GLARGINE; INSULIN LISPRO; ISOPHANE INSULIN;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; DRUG DELIVERY SYSTEM; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MEDICAL AUDIT; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT ATTITUDE; PATIENT SATISFACTION; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; TREATMENT OUTCOME;

DIABETES MELLITUS; FAMILY; FOOD HABITS; HEALTH STATUS; HUMANS; PATIENT SATISFACTION; PERCEPTION; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 0036710709     PISSN: 15207552     EISSN: None     Source Type: Journal    
DOI: 10.1002/dmrr.279     Document Type: Article

References (21)

1. Bradley C (ed). Diabetes Treatment Satisfaction Questionnaire. In Handbook of Psychology and Diabetes: A Guide to Psychological Measurement in Diabetes Research and Practice. Harwood Academic, 1994; 111-152.
2. Bradley C, Todd C, Gorton T, Symonds E, Martin A, Plowright R. The development of an individualized questionnaire measure of perceived impact of diabetes on quality of life: the ADDQoL. Qual Life Res 1999; 8: 79-91.
3. Bradley C. The Well-being Questionnaire. In Handbook of Psychology and Diabetes: A Guide To Psychological Measurement in Diabetes Research and Practice, Bradley C (ed.). Harwood Academic, 1994; 89-109.
4. Bradley C, Gamsu DS. Guidelines for encouraging psychological well-being: report of a working group of the World Health Organization Regional Office for Europe and International Diabetes Federation European Region St Vincent Declaration Action Programme for Diabetes. Diabet Med 1994; 11: 510-516.
5. Jennings AM, Lewis KS, Murdoch S, Talbot JF, Bradley C, Ward JD. Randomized trial comparing continuous subcutaneous insulin infusion and conventional insulin therapy in type II diabetic patients poorly controlled with sulfonylureas. Diabetes Care 1991; 14: 738-744.
6. Taylor R, Foster D, Kyne-Grzebalski D, Vanderpump M. Insulin regimens for the non-insulin dependent: impact on diurnal metabolic state and quality of life. Diabet Med 1994; 11: 551-557.
7. Witthaus E, Stewart J, Bradley C. Improved psychological outcomes after initiation of insulin treatment in patients with type II diabetes. Diabetologia 2000; 43 (Suppl. 1): A205 (Abstract 787).
8. Janes JM, Bradley C, Rees A. Preferences for, and improvements in aspects of quality of life (QOL) with, insulin lispro in a multiple injection regimen (Abstract). Diabetologia 1997; 40 (Suppl. 1): A353.
9. Renner R, Pfützner A, Trautmann M, Harzer O, Sauter K, Landgraf R, on behalf of the German Humalog-CSII Study Group. Use of insulin lispro in continuous subcutaneous insulin infusion treatment. Diabetes Care 1999; 22: 784-788.
10. Howorka K, Pumprla J, Schlusche C, Wagner-Nosiska M, Shabmann A, Bradley C. Dealing with ceiling baseline treatment satisfaction level in patients with diabetes under flexible, functional insulin treatment: assessment of improvements in treatment satisfaction with a new insulin analogue. Qual Life Res 2000; 9: 915-930.
11. Heinemann L, Linkeschova R, Rave K, Hompesch B, Sedlak M, Heise T. Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo. Diabetes Care 2000; 23: 644-649.
12. Bradley C, Witthaus E, Stewart J. Treatment satisfaction and psychological well-being in patients with type I diabetes, treated with a new long-acting insulin insulin glargine. Diabetes 1999; 48 (Suppl. 1): A353 (Abstract 1547).
13. Witthaus E, Stewart J, Bradley C. Treatment satisfaction and psychological well-being with insulin glargine compared with NPH in patients with type 1 diabetes. Diabet Med 2001; 16: 619-625.
14. Bradley C. Diabetes treatment satisfaction questionnaire. Change version for use alongside status version provides appropriate solution where ceiling effects occur. Diabetes Care 1999; 22: 530-532.
15. Bradley C, Plowright R, Stewart J, Witthaus E. Diabetes treatment satisfaction questionnaire (change) in English and German evaluated in insulin glargine trials. Diabetologia 2000; 43 (Suppl. 1): A196 (Abstract 754).
16. McGee HM, O'Boyle CA, Hickey A, O'Malley K, Joyce CR. Assessing the quality of life of the individual: the SEIQoL with a healthy and a gastroenterology unit population. Psychol Med 1991; 21: 749-759.
17. Bradley C. Design of a renal-dependent individualized quality of life questionnaire. Adv Perit Dial 1997; 13: 116-120.
18. Speight J, Barendse S, Bradley C. The DIABQoL+ Programme. Proc Br Psych Soc 1999; 7: 35.
19. Speight J, Bradley C. ADDQoL indicates negative impact of diabetes on quality of life despite high levels of satisfaction with treatment. Diabetologia 2000; 43 (Suppl. 1): A225 (Abstract 864).
20. Mühlhauser I, Bruckner I, Berger M, et al. Evaluation of an intensified insulin treatment and teaching programme as routine management of type 1 (insulin-dependent) diabetes. The Bucharest-Dusseldorf Study. Diabetologia 1987; 30: 681-690.
21. The DAFNE Group. The DAFNE (Dose Adjustment For Normal Eating) Trial: the end of the diabetic diet in Type 1 diabetes. Diabet Med 2002; 19 (Suppl. 2): 3.